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Abstract
Successful human colonizers such as Candida pathogens have evolved distinct strategies
to survive and proliferate within the human host. These include sophisticated mechanisms
to evade immune surveillance and adapt to constantly changing host microenvironments
where nutrient limitation, pH fluctuations, oxygen deprivation, changes in temperature, or
exposure to oxidative, nitrosative, and cationic stresses may occur. Here, we review the cur-
rent knowledge and recent findings highlighting the remarkable ability of medically important
Candida species to overcome a broad range of host-imposed constraints and how this
directly affects their physiology and pathogenicity. We also consider the impact of these
adaptation mechanisms on immune recognition, biofilm formation, and antifungal drug resis-
tance, as these pathogens often exploit specific host constraints to establish a successful
infection. Recent studies of adaptive responses to physiological niches have improved our
understanding of the mechanisms established by fungal pathogens to evade the immune
system and colonize the host, which may facilitate the design of innovative diagnostic tests
and therapeutic approaches for Candida infections.
Introduction
The human body is home to a large number of microbes that play essential roles in maintain-
ing human health. However, under particular host-compromising conditions, they can shift
from harmless commensals to opportunistic pathogens to cause inflammation and disease.
Fungal communities, which can include Candida species, constitute an integral part of the
human microbiota that, under normal conditions, asymptomatically colonize several niches,
including the skin, oral cavity, gastrointestinal, and urogenital tracts [1–3]. The remarkable
ability to alternate between local current microenvironments within internal host niches such
as blood or tissues is often linked with their pathogenic potential. Therefore, environmental
changes promoted either by alterations in host microbiota or the host immune system may
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allow these microorganisms to overgrow, cross the epithelial barriers, and cause severe, life-
threatening infections [4].
Among the Candida species that trigger human disease, Candida albicans, C. glabrata, C.
parapsilosis, C. tropicallis, and C. krusei are the most common [4–6]. Yet, other emerging spe-
cies, including C. auris, C. guilliermondii, C. lusitaniae, and C. metapsilosis, are of particular
concern because they are rapidly spreading worldwide, with several reported outbreaks [5,7,8].
Moreover, Candida infections are difficult to diagnose, commonly resulting in delayed anti-
fungal treatments that have been associated with hospital mortality [9]. The antifungal drugs
available to eradicate these fungal pathogens are also limited and often ineffective, mainly
because of the intrinsic multidrug resistance of certain Candida species and their ability to
form biofilms on implanted medical devices [10–12]. Considering that each species presents
its own distinctive features in relation to invasive potential, morphogenesis, antifungal suscep-
tibility, and biofilm formation, studies focusing on the adaptation to different hosts and envi-
ronmental factors have the potential to reveal novel molecular players of virulence pathways.
Here, we provide an overview of established and emerging strategies used by Candida to
adapt to common environmental challenges faced by these fungi during immune evasion and
human colonization (Fig 1). As we review major host-imposed constraints, we highlight the
central regulatory circuits required for fungal adaptation to these constraints. We also discuss
the impact of such physiological reprogramming on key aspects of Candida pathogenicity,
with a particular emphasis on immune evasion, biofilm formation, and antifungal drug
Fig 1. Candida biogeography and the different host-imposed constraints during human colonization. The most frequently isolated Candida species
are listed according to their principal habitat in the human body (oral cavity, lungs, gastrointestinal tract, bloodstream, urogenital tract, and skin). The
different host-imposed constraints are highlighted for several microenvironments where Candida thrives in the human body, including inside
phagocytic cells or biofilms. Key references: C. albicans [2,3], C. glabrata [3], C. parapsilosis [2], C. tropicalis [2], C. lusitaniae [13], and C. krusei [6].
ECM, extracellular matrix; NOS, nitric oxide species; ROS, reactive oxygen species; UG, urogenital.
https://doi.org/10.1371/journal.ppat.1008478.g001
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resistance. We propose that the genetic circuits governing Candida adaptation to human
niches can be exploited in search of new antifungal targets and diagnosis improvement.
Candida within the human host
The human host contains a variety of environmental niches in which Candida species can
thrive. Adaptation to these sites requires rapid and coordinated changes in Candida metabo-
lism and physiology in order to avoid or escape immune surveillance and to counteract several
host-imposed constraints (for example, nutrient limitation, oxygen deprivation, pH fluctua-
tions, changes in temperature, or oxidative, nitrosative, and cationic stresses). Moreover, Can-
dida species interact with other microbial residents, establishing either cooperative or
antagonistic relationships, which may affect their growth and influence the outcome of an
infection.
Depending on the local environmental cues, some Candida species may exhibit different
cellular morphologies. These include budding forms, which have been associated with com-
mensalism, and the filamentous forms hyphae and pseudohyphae, often related with invasive
and disseminated disease [14,15]. However, these cell types were found in infected tissues, sug-
gesting they all promote pathogenicity. C. albicans has also the ability to switch into more
functionally and genotypically distinct cell types, which may present improved fitness in spe-
cific host niches [15]. In particular, “white” yeast cells can switch to mating specialized
“opaque” cells, and a subset of these can also transit into a third, “gray” morphology [16]. An
additional distinctive group of cells, known as GUT (gastrointestinally induced transition),
seems to display enhanced fitness in the gastrointestinal tract when compared with other cell
types [17]. The morphogenic transitions depend on a highly dynamic cell wall that acts as an
environmental barrier, and it is essential for host–pathogen interactions. The core skeleton of
the cell wall is composed of the polysaccharide β-1,3-glucan, covalently linked to β-1,6-glucan
and chitin. The outer layer contains glycosylated mannoproteins cross-linked to β-1,6-glucans.
The relative amount of each component fluctuates between morphologies and in response to
external challenges, impacting immune responses [18,19].
Nutrient availability and Candida metabolic flexibility
Of the many challenges pathogens face in the human host, possibly none is more important
than nutrient availability because cells must assimilate nutrients in order to thrive. These
might include sugars, carboxylic acids, peptides, amino acids, lipids, or phospholipids. The
assimilation of glucose, lactose, and galactose is mediated via hexose transporters (HGTs), pro-
viding major sources of energy and carbon (Fig 2a). The well-studied yeast model Saccharomy-
ces cerevisiae, which is relatively closely related to some Candida species, uses glucose as a
preferred carbon source and only switches to nonfermentable nutrients when glucose becomes
depleted [20]. This hierarchical utilization requires highly evolved networks integrating several
signaling pathways in order to repress the assimilation of alternative carbon sources [21–24].
This is partly achieved by the ubiquitination of key gluconeogenic and glyoxylate cycle
enzymes following the exposure to glucose [25]. Notably, these enzymes appear to lack ubiqui-
tination sites in C. albicans, C. glabrata, C. parapsilosis, and C. tropicalis, and consequently,
they are not subjected to glucose-induced degradation [26,27]. The evolutionary rewiring of
key metabolic ubiquitination targets has been suggested to increase the ability of C. albicans to
colonize and cause infection in the mammalian host because, unlike S. cerevisiae, this yeast is
able to assimilate sugars and alternative carbon sources simultaneously [26–28]. The availabil-
ity of glucose is thought to enhance C. albicans virulence owing to the fact that this sugar has
been reported to induce hyphal morphogenesis at low physiological concentrations [29–31]
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and promote antifungal resistance [32,33]. Moreover, rapid glucose metabolism by C. albicans
seems to be important during infection because immune cells, specifically macrophages, rely
on glucose for survival [34]. This limitation is exploited by C. albicans, which elicits rapid mac-
rophage death by depleting the available glucose [34].
In glucose-limiting conditions, other alternative carbon sources, such as N-acetylglucosa-
mine (GlcNAc) and carboxylic acids, are thought to play a critical role to sustain Candida
growth. When infecting tissues and organs, Candida up-regulates several pathways involved in
the utilization of alternative carbon sources, such as gluconeogenesis, the glyoxylate cycle, and
fatty acid β-oxidation, suggesting that glucose levels may not be sufficient to satisfy the ener-
getic requirements of the cells [28,35–37]. In C. albicans and C. tropicalis, GlcNAc, a monosac-
charide produced mainly by bacteria in the gastrointestinal tract, enters the cell through the
Ngt1 transporter, and is then sensed by the transcription factors, Ngs1 and Rep1, which con-
trol the expression of genes involved in the uptake and catabolism of GlcNAc [38–40] (Fig 2b).
Depending on the metabolic state of the cells, GlcNAc can either be converted to uridine
diphosphate-N-acetylglucosamine (UDP-GlcNAc) or to fructose-6-phosphate, which then
Fig 2. Schematic representation of the main sensing, transport, and transduction systems for the utilization of different host nutrients in
Candida species. (a) In C. albicans, glucose is sensed by Hgt4, generating an intracellular signal that induces the expression of HGTs and other
metabolic genes. (b) In C. albicans and C. tropicalis, the uptake of GlcNAc occurs through the Ngt1 transporter. (c) The uptake of carboxylic acids is
facilitated by the Jen (in C. albicans) and Ato transporters (in C. albicans and C. glabrata). In C. albicans, Gpr1 is reported to be a lactate and
methionine sensor. In the presence of lactate, Gpr1 is thought to activate Crz1 in a calcineurin-independent manner and, together with Ace2, regulates
a polygenic response that leads to β-glucan masking. (d) Peptides and amino acids are sensed by the SPS complex, which induces the expression of
Opts, Aaps, and Ato transporters, as well as SAPs and amino acid catabolic genes. Intracellular ammonia resulting from the catabolism of GlcNAc or
amino acids is exported via Ato transporters. In the presence of methionine, and in low glucose conditions, the methionine-induced morphogenesis is
activated via Gpr1 sensor and Mup1 transporter. AA, amino acid; Aap, amino acid permease; ATP, adenosine triphosphate; cAMP, cyclic adenosine
monophosphate; DcSAM, decarboxylated S-adenosylmethionine; GlcNAc, N-acetylglucosamine; GPI, glycosylphosphatidylinositol; HGT, hexose
transporter; Opt, oligopeptide transporter; SAM, S-adenosylmethionine; SAP, secretory aspartyl proteinase; SPS, Ssy1-Ptr3-SSy5; Sp2DC, Sp2
decarboxylase; TCA, tricarboxylic acid cycle; UDP, uridine diphosphate.
https://doi.org/10.1371/journal.ppat.1008478.g002
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enters the glycolytic pathway (Fig 2b). In C. albicans, GlcNAc can also be used as a signal to
induce the expression of several virulence genes involved in white-opaque switching [41],
hyphal morphogenesis [38–40,42], and cell death [43]. Additionally, GlcNAc metabolism
seems to sustain Candida survival when growing inside phagocytic cells. The export of intra-
cellular ammonia, derived from GlcNAc catabolism, has been reported to promote the alkali-
zation of the phagosome, enabling cells to survive and escape from the acidic environment of
the phagolysosome [44]. This mechanism is dependent on the transport of GlcNAc and subse-
quent catabolism through Hxk1, Nag1, and Dac1 enzymes [44]. Hence, mutants lacking the
Ngt1 transporter or GlcNAc catabolic enzymes are defective in neutralizing the phagosome
[44]. The ability to manipulate ambient pH is reported for all species of the CTG clade, a phy-
logenetic group that translates the CUG codon into serine instead of leucine [45]. This is in
contrast to what is found for the distantly related C. glabrata, whose genome does not appear
to encode homologs of GlcNAc transporters or catabolic enzymes [44].
C. albicans can also raise the extracellular pH by metabolizing carboxylic acids [46]. This
phenomenon is physiologically and genetically distinct from the GlcNAc-driven mechanism,
as the metabolism of carboxylic acids, when used as the sole carbon source, does not generate
ammonia or promote hyphal morphogenesis [44,46]. Physiologically relevant carboxylic acids
such as lactate, acetate, succinate, butyrate, and propionate are produced either by host cells or
host microbiota [47–49]. Lactate and acetate are particularly abundant in the gut and in vagi-
nal secretions [47,50] but also inside phagocytic cells [51,52]. In C. albicans, the uptake of lac-
tate is mediated by Jen transporters [51,53], while Ato transporters are potentially involved in
the transport of acetate in both C. albicans and C. glabrata [52,54] (Fig 2c). These two trans-
porter families are strongly induced after phagocytosis [51,52], and they modulate biofilm for-
mation and resistance to antifungal drugs in both C. albicans and C. glabrata [54–56]. In
particular, exposure to lactate has been shown to trigger the masking of β-glucan, a major
pathogen-associated molecular pattern (PAMP), in several Candida species [57]. This affects
the visibility of these pathogens to host immune defenses, which correlates well with the
observed decrease in C. albicans uptake by macrophages and reduced phagocytic recruitment
[57,58]. The β-glucan masking phenotype has been proposed to be dependent on Gpr1 and
the transcription factor Crz1 [57]. These proteins control the expression of genes associated
with the organization of the cell wall, ultimately contributing to the masking effect [57,59].
Therefore, the concomitant exposure of Candida cells to different carboxylic acids potentiates
immune evasion and consequently Candida persistence.
The uptake of nitrogen is also critical for Candida survival. Different in vivo studies have
demonstrated that genes involved in amino acid uptake and catabolism are strongly up-regu-
lated in C. albicans, especially when phagocytosed by neutrophils and macrophages [36,60–
62]. Indeed, several C. albicans and C. glabrata amino acid auxotrophic strains retain full viru-
lence in mice, suggesting that these nutrients are readily available during infection [63–65].
Proteolytic enzymes, namely secretory aspartyl proteinases (SAPs), are of particular impor-
tance because they allow Candida to efficiently degrade the complement proteins and host
connective tissues [66]. Once available, extracellular amino acids are then sensed by the SPS
complex (composed of Ssy1, Ptr3, and Ssy5), which in turn activates the transcription factors,
Stp1 and Stp2 (Fig 2d). While Stp1 controls the expression of extracellular proteases and pep-
tide transporters, Stp2 regulates amino acid permeases, Ato transporters, and catabolic
enzymes [67,68] (Fig 2d). Along with GlcNAc and carboxylic acids, the catabolism of amino
acids represents a third independent mechanism by which Candida rapidly neutralizes acidic
microenvironments [52,69]. Previous studies reported that C. albicans mutants lacking STP2
or ATO genes release less ammonia than wild-type controls, failing to efficiently neutralize the
acidic phagosome and undergo hyphal morphogenesis, which consequently affects their ability
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to escape phagocytic cells [52,70]. Recent data, however, suggest that the phagosomal membrane
is highly permeable to ammonia, and the observed alkalization is rather a direct consequence of
proton leakage induced by hyphal growth [71,72]. The transport of methionine via the high-
affinity permease Mup1 and its subsequent metabolism have been also shown to induce mor-
phogenesis in a process that is dependent on Gpr1 and the cAMP-PKA (cyclic Adenosine
Monophosphate-Protein Kinase A) signaling cascade [73,74]. The methionine-induced mor-
phogenesis pathway triggers the activation of adenylate cyclase by the production of increased
levels of polyamines such as spermine and spermidine. These compounds are generated by the
intracellular conversion of methionine into S-adenosylmethionine (SAM) and its decarboxyl-
ation by Spe2, which donates aminopropyl groups for polyamine synthesis [73] (Fig 2d).
Environmental pH fluctuations shape Candida physiology and
pathogenicity
Changes in ambient pH represent an additional stress that Candida and other pathogens face
in the human host. While the pH of human blood and tissues is slightly alkaline (pH 7.4), the
pH of the oral cavity and the gastrointestinal and genitourinary tracts is acidic (2 < pH< 6).
Adaptation to differing ambient pHs is critical for survival and growth in these niches. In
fungi, including Candida species, pH signaling is mediated by the Rim pathway [75]. In C.
albicans, the external pH is sensed by Rim21/Dfg16, Rim9, and an arrestin-like protein Rim8.
Under alkaline pH, Rim8 is hyperphosphorylated, a signal that triggers the endocytosis of the
plasma membrane complex and the recruitment of the signaling protease Rim13. This protease
then cleaves the C-terminal inhibitory domain of Rim101, resulting in its activation. The acti-
vation of Rim101 promotes the expression of target genes involved in morphogenesis [76–79],
growth [80], cell-wall remodeling [80], iron metabolism [81,82], adhesion [80], biofilm forma-
tion, and antifungal tolerance [75,83,84] (Fig 3).
On the other hand, the adaptation of C. albicans to acidic environments drives cell-wall
remodeling by enhancing the exposure of two key fungal PAMPs (chitin and β-glucan) at the
cell surface [85]. While pH-dependent β-glucan exposure is regulated by a noncanonical sig-
naling pathway, the remodeling of chitin is coordinated by several transcription factors,
including Rim101, Bcr1, and Efg1 (Fig 3) [85,86]. The exposure of β-glucan at the cell surface
hyperactivates the immune system largely through the recognition of the immunostimulatory
β-glucan by Dectin-1, which enhances the recruitment of neutrophils and macrophages to the
site of the infection [85]. This pH-dependent β-glucan exposure was also observed in C. dubli-
niensis and C. tropicalis, but not in C. auris or C. glabrata [85,86]. Surprisingly, adaptation to
acidic environments induces β-glucan masking in C. krusei, suggesting that the outputs of pH-
dependent signal transduction differ between these Candida species [85]. Additionally, the
pH-dependent reorganization of the cell wall fluctuates over time in C. albicans, with β-glucan
and chitin being masked after an initial period of exposure [86]. While the subsequent β-glu-
can masking is mediated by farnesol, this quorum-sensing molecule does not trigger the chitin
cloaking [86]. These temporal fluctuations suggest dynamic cell-wall responses to environ-
mental pH. Moreover, the early PAMP exposure appears to govern the outcome of the infec-
tion because subsequent remasking on the cell wall does not compensate for the initial
induction of strong proinflammatory responses [86].
Adaptation to oxygen-limiting niches is critical for Candida
virulence
Oxygen levels inside the human host can vary greatly. While some niches are rich in oxygen,
such as exposed skin or oral mucosa, others are anoxic or hypoxic, including the
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gastrointestinal tract [87]. Consequently, Candida cells must adapt to low-oxygen environ-
ments, particularly when colonizing the human gut, developing lesions or growing in biofilms
[87,88]. Analyses of gene expression profiles of C. albicans cells shifted from normoxia to hyp-
oxic growth conditions revealed the induction of several pathways, including glycolytic gene
expression via Tye7 [89–91], fatty acid metabolism [92,93], heme biosynthesis and iron metab-
olism [89,92,94], cell-wall structure [89,92,94], and sterol biosynthesis via Upc2 [95,96]. In
contrast, genes involved in the oxidative respiration were repressed [89,92,94]. Additionally,
the Sit4 phosphatase, the Ccr4 mRNA deacetylase, and the Sko1 transcription factor have been
identified as potential regulators of an early hypoxic response (10–20 min) [91,94].
Besides affecting the cellular metabolism and energy homeostasis, adaptation to hypoxia
induces hyphal growth in C. albicans [94] and promotes immune evasion by triggering β-glu-
can masking at the cell surface [97]. β-glucan masking leads to reduced phagocytosis and
attenuates local immune responses [97]. In contrast to lactate-induced β-glucan masking, hyp-
oxia-induced masking does not depend on Gpr1 and Crz1. Instead, hypoxia-induced masking
is mediated by mitochondrial and cAMP-PKA signaling [57,97]. Hypoxia induces the genera-
tion of mitochondrial superoxide [98,99], which is rapidly converted into diffusible hydrogen
peroxide by superoxide dismutase 1 (Fig 4). Hydrogen peroxide has been proposed to some-
how activate the cAMP-PKA pathway, which, in turn, triggers cell-wall remodeling and β-glu-
can masking [97]. However, the mechanism by which β-glucan masking is achieved at the cell
surface remains unclear.
Fig 3. Candida adaptation to pH fluctuations. In Candida species, pH adaptation is mediated by the Rim pathway. Under acidic
pH, the exposure of both chitin and β-glucan is enhanced and facilitates their recognition by the host innate immune system. Chitin
exposure is promoted by the repression of both Rim101 and Bcr1, resulting in reduced expression of CHT2. β-glucan exposure is
regulated by a noncanonical signaling pathway. Under alkaline pH, Rim8 is hyperphosphorylated, a signal that induces the
endocytosis of the Rim complex and the recruitment of Rim13. The C-terminal proteolysis of Rim101 by Rim13 activates it and
promotes the expression of target genes, including CHT2.
https://doi.org/10.1371/journal.ppat.1008478.g003
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Hypoxia-induced β-glucan masking has been observed for some other pathogenic Candida
species, namely C. tropicalis and C. krusei, but not in C. glabrata, C. guilliermondi, or C. para-
psilosis [97]. Therefore, during their evolution, hypoxic signaling has become integrated with
PAMP masking only in some Candida pathogens. The adaptation to hypoxic environments
enhances the ability of these Candida species to colonize the host. For example, it was shown
that the recruitment of polymorphonuclear leukocytes (PMNs) to sites of C. albicans infection
in mice was the main cause of hypoxia [88] (Fig 4). However, because of the hypoxia-induced
β-glucan masking by C. albicans cells, these PMNs are not able to efficiently phagocytose the
fungus, generate reactive oxygen species (ROS), or release extracellular DNA traps, allowing C.
albicans to survive. Continued exposure to hypoxia leads to accumulation of lactate, prolong-
ing the masking effect. Additionally, it was also observed that the antifungal activity of flucona-
zole is considerably reduced under hypoxic conditions. We speculate that the molecular
mechanism behind this observation might include Upc2, considering its dual role in activating
hypoxia-induced β-glucan masking [97] and conferring azole antifungal resistance [100]. In
contrast to C. albicans, C. tropicalis is not able to induce β-glucan masking in response to hyp-
oxia, and this species is more susceptible to PMN attack [88]. This is in agreement with the
fact that C. tropicalis mainly infects neutropenic patients [101]. The molecular mechanisms
allowing hypoxic adaptation are not completely defined. Nevertheless, it is clear that some
Candida species take advantage of low-oxygen environments, either generated during infec-
tion or imposed by the specific host niche, to thrive by avoiding immune surveillance and
escaping from antifungal therapy.
Fig 4. Candida adaptation to hypoxic host niches. During C. albicans infections, the recruitment of PMNs creates an hypoxic
environment [88]. In the fungus, this oxygen limitation triggers increased formation of ROS, such as superoxide (O2
•−), from the
electron transport chain [98,99]. Superoxide is then converted into diffusible hydrogen peroxide (H2O2) by the action of Sod1. H2O2
has been proposed to activate adenylyl cyclase (Cyr1) and cAMP-PKA (Tpk1/2) signaling, which in turn triggers cell-wall
remodeling and β-glucan masking [97]. This β-glucan masking allows the fungus to evade phagocytosis by the PMNs [88]. cAMP,
cyclic Adenosine Monophosphate; NET, neutrophil extracellular trap; PKA, Protein Kinase A; PMN, polymorphonuclear leukocyte;
ROS, reactive oxygen species; Sod1, superoxide dismutase 1.
https://doi.org/10.1371/journal.ppat.1008478.g004
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Candida adaptation to temperature shifts is essential for full
virulence
The human body temperature is considered to be a potent nonspecific defense against fungal
infection, especially in febrile patients, because high temperatures considerably restrict fungal
growth [102,103]. The human host presents fever as one of the first responses against a Can-
dida infection, thereby exposing the fungal cells to temperatures ranging from 37 ˚C to 42 ˚C.
These temperature fluctuations profoundly influence many physiological aspects of C. albi-
cans, including morphology, mating, phenotypic switching, and drug resistance [104].
Changes in ambient temperature are sensed by a broad diversity of mechanisms. One of the
most studied pathways is the evolutionarily conserved heat shock response, which mediates
thermal homeostasis by controlling the levels of heat shock proteins (HSPs) [105]. HSPs are
molecular chaperones sequestered in response to heat shock, rescuing proteins from unfolding
or targeting damaged proteins for degradation. In C. albicans, the expression of HSP genes is
activated by the heat shock transcription factor 1 (Hsf1), which becomes phosphorylated in
response to temperature elevations, including thermal transitions that mimic fever [106,107].
After adaptation to the exposed temperature, Hsf1 phosphorylation returns to basal levels and
several lines of evidence have suggested the existence of a negative feedback loop, in which
Hsp90 negatively regulates Hsf1 [107–109]. Besides Hsf1, Hsp90 also controls the activation of
other regulators that mediate long-term thermal adaptation (Fig 5). These include several
mitogen-activated protein kinase (MAPK) signaling pathways, particularly the Hog1, Mkc1,
and Cek1 pathways, which are intimately associated with cell-wall remodeling [110,111].
Other small HSPs such as Hsp12 and Hsp21 have also been identified as crucial for C. albicans
Fig 5. Molecular circuits required for thermal adaptation in C. albicans. (a) HSPs rescue proteins from unfolding or target
damaged proteins for degradation. (b) In response to temperature upshifts, Hsf1 becomes phosphorylated, inducing the expression
of HSP genes. After thermal adaptation, Hsf1 returns to basal levels through a negative feedback loop dependent on Hsp90. Long-
term adaptation is controlled by Hsp90 through Hog1, Mkc1, and Cek1. HSE, heat shock element; Hsf1, heat shock transcription
factor 1; HSP, heat shock protein; MAPK, mitogen-activated protein kinase; MAPKK/MAPKKK, MAPK kinase/ MAPKK kinase.
https://doi.org/10.1371/journal.ppat.1008478.g005
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to resist thermal stress [112,113]. HSPs and their associated signaling pathways have been
widely implicated in antifungal resistance, emerging as potential antifungal targets to treat
Candida infections [114]. Moreover, the activation of the Hsf1 transcriptional program in C.
albicans has been associated with increased host cell adhesion, damage, and virulence, rein-
forcing the importance of this regulon in thermal homeostasis [115,116].
Candida and host microbiota: Avoiding antagonistic interactions
in health and disease
The structure of human microbiota is dynamic, often defined by host and environmental fac-
tors and also by physical and metabolic interactions between species. While some of these
interactions are cooperative, others are antagonistic, and the latter may represent a major
obstacle for Candida. This concept gained experimental support through studies involving the
depletion of commensal microbiota by continued use of broad-spectrum antibiotics, which
resulted in Candida overgrowth [117,118]. This suggests that some commensal microbial colo-
nizers antagonize Candida spp. (and other exogenous pathogens) in order to maintain a
homeostatic balance in the host. Some of these interactions are driven by metabolic competi-
tion, while others are mediated by quorum-sensing molecules that influence fungal cell behav-
ior and regulate important virulence traits. Although quorum-sensing systems have been
explored in great detail for pathogenic bacteria, they are relatively poorly understood in fungi
[119]. The C. albicans molecule farnesol was the first quorum-sensing compound to be identi-
fied in an eukaryote [120] and has been the object of intense research. Yet, its precise mode of
action remains unclear.
Lactobacillus species and C. albicans are a well-documented example of infectious antago-
nism [121–123]. Lactobacilli are a dominant species of the microbiota of the gastrointestinal
and urogenital tracts, and they actively reduce the amount of fungal microbes by producing
many fungicidal compounds [121–123]. Other commensal bacteria such as Bacteroides the-
taiotamicron or Blautia producta can antagonize C. albicans by stimulating intestinal cells to
produce antimicrobial peptides [124]. The pathogenic bacterium Acinetobacter baumanii has
been also reported to interact antagonistically with C. albicans by binding to hyphae to pro-
mote apoptosis [125]. The elucidation of these types of interaction are of particular interest in
the quest for novel targets for antifungal therapy, as the inhibitory secreted factors produced
by these antagonists appear to have high fungicidal activity.
The disruption of commensal interactions through alterations in immune competence, by
changes in environmental host conditions, or via antibiotic therapy may favor the outgrowth
and overrepresentation of pathogenic microbes, with these growing at the expense of those
organisms that fail to adapt. While antagonist interactions might lower the risk of infection,
synergistic interactions during dysbiotic states are associated with increased pathogenesis
because microbes can also interact to enhance colonization and persistence. An illustrative
example is the infectious synergism established between several Candida species (including C.
albicans, C. dubliniensis, C. tropicalis, and C. krusei) and the gram-positive bacterium Staphylo-
coccus aureus [126,127]. Candida not only provides a substratum for the attachment and colo-
nization of S. aureus but also facilitates its invasion across mucosal barriers, thereby
promoting persistence and systemic infection [128].
Host immune defenses: How Candida species counteract the
immune response
Microbial pathogens are constantly surveyed by the innate immune system. Phagocytic cells
such as dendritic cells, macrophages, monocytes, and neutrophils play important roles in
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clearing fungal pathogens from the bloodstream and tissues. Loss of innate immune cells or
defects in their antifungal activities have major implications for the host. Candida cells are rec-
ognized through key PAMPs, some of which are located in the cell wall; for example, β-glu-
cans, chitin, and mannans. These components are sensed by the multiple pattern-recognition
receptors (PRRs) expressed by phagocytic cells or secreted (for example, complement compo-
nents). PPRs mediate binding of the pathogen to the phagocyte, and the PAMP–PRR interac-
tions trigger intracellular signaling pathways within the immune cells that can induce
phagocytosis and the production of proinflammatory cytokines and chemokines. In order to
attenuate recognition and escape phagocytosis, Candida cells are able to actively mask cell-wall
PAMPs [129] and secrete specific proteases that target complement opsonization [130]. Alter-
natively, some Candida species can induce their phagocytic uptake into endothelial and epithe-
lial cells and use these cells as “safe houses” by preventing maturation of the phagolysosome
and subsequent killing [131]. If none of these strategies is employed, Candida cells are likely to
be internalized and subjected to a combination of toxic oxidative and nonoxidative mecha-
nisms that attempt to kill an intra- or extracellular yeast cell. These oxidative mechanisms
include the production of reactive oxygen and nitrogen species (ROS and RNS, respectively),
while nonoxidative killing mechanisms include the release of antimicrobial peptides and the
induction of processes related to micronutrient restriction. Of note, while C. albicans is sensi-
tive to the combinatorial stresses imposed by phagocytes [132], C. glabrata has adapted to sur-
vive within the inhospitable environment of the phagosome. This pathogen mounts robust
stress responses against the ROS implemented by the phagocytic cell and neutralizes the
phagocytic environment, thereby escaping phagocytosis [133].
Oxidative, nitrosative, and osmotic/cationic stresses
Phagocytic cells attempt to kill pathogens in part by employing toxic ROS and RNS, either
intracellularly or extracellularly, as a major antimicrobial defense mechanism. ROS are pro-
duced by the NADPH oxidase complex, a process known as respiratory burst, and include
chemicals such as the superoxide anion (O2
•), hydrogen peroxide (H2O2), and the hydroxyl
radicle (•OH). Furthermore, ROS production in response to C. albicans infection has been
shown to lead to the recruitment of additional phagocytes, creating a toxic oxidative environ-
ment for the fungus [134]. Inside phagocytes, ROS can interact with nitric oxide (NO), gener-
ating toxic products such as peroxynitrite [135]. These toxic chemicals cause irreversible
damage to the pathogen by interacting with proteins, lipids, and nucleic acids.
Candida species attempt to counteract these stresses by activating cellular responses that
include the activation of genes encoding proteins involved in stress detoxification and repara-
tion. These include catalase, superoxide dismutases, glutathione peroxidases, and thioredoxins
(Fig 6a) [136–138]. In C. albicans and C. glabrata, these stress pathways are regulated largely
by the Hog1 stress-activated protein kinase [136,139], the transcription factor Cap1 [140–142],
and the Rad53 DNA damage checkpoint kinase [143]. Together with the transcription factor
Cta4, these signaling pathways play key roles in orchestrating the responses to osmotic, oxida-
tive, and nitrosative stresses in these species [144]. In this way, these regulators promote the fit-
ness of C. albicans during systemic infection. Indeed, mutants lacking these genes display
attenuated virulence in mice, as well impaired tolerance to these stresses in vitro and phago-
cytic survival [145,146]. Curiously, the oxidative stress response is delayed if the fungus is
simultaneously exposed to cationic and oxidative stress [147]. This is thought to contribute to
the ability of phagocytic cells to efficiently kill invading pathogens (Fig 6a) [132]. Given the
importance of these stress response pathways for Candida survival, key molecular players
involved may represent attractive targets for antifungal development.
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Fig 6. Host immune defenses and adaptation mechanisms displayed by C. albicans and C. glabrata. (a) Cap1 plays a key role in
the activation of responses to ROS generated by phagocytic cells, leading to the induction of oxidative stress genes (XS genes),
including catalase, superoxide dismutases, glutathione peroxidases, and thioredoxins, among others. However, cations inhibit
catalase and Cap1, thereby delaying the induction of the oxidative stress response and leading to the death of C. albicans cells. (b)
Host-enforced micronutrient restriction results in reduced iron, copper, and zinc availability, but C. albicans responds by up-
regulating efficient metal-scavenging strategies. Host phagocytes also exploit the toxicity of copper and zinc by pumping these metals
in excess into phagosomes to intoxicate internalized pathogens. NOS, nitric oxide species; PM, plasma membrane; ROS, reactive
oxygen species; Sod, superoxide dismutase; XS, oxidative stress.
https://doi.org/10.1371/journal.ppat.1008478.g006
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Host-enforced micronutrient restriction
The limitation of micronutrients such as iron, copper, zinc, or manganese is an effective way
of controlling the outgrowth of invading microbes. These micronutrients are essential for the
survival of both host and pathogen because they function as cofactors for enzymes, transcrip-
tion factors, and other proteins that play crucial biochemical and cellular functions. However,
our immune system attempts to restrict microbial access to these essential elements via a
mechanism known as nutritional immunity [148].
Iron has well-studied implications for Candida pathogenesis, being a crucial micronutrient
for Candida growth, survival, and virulence [149]. During systemic candidiasis, the host
restricts this metal by increasing the levels of iron-binding proteins, such as ferritin and hemo-
globin alpha, and accumulating heme oxygenase (Fig 6b) [150,151]. Both C. albicans and C.
glabrata have developed efficient iron-scavenging strategies that can overcome these host
mechanisms. This contributes to their ability to survive phagocytosis and replicate inside mac-
rophages by using their intracellular storages of iron [152,153]. C. albicans and C. glabrata
cells exploit sophisticated iron-uptake systems to acquire either free iron [154,155] or iron
from host iron-binding proteins, including hemoglobin [156], ferritin [82], and transferrin
(Fig 6b). Additionally, the utilization of siderophores promotes resistance to macrophage kill-
ing: in C. glabrata, the Sit1 siderophore-iron transporter mediates iron acquisition, being criti-
cal for the survival of the yeast inside macrophages [152].
Copper is also involved in Candida virulence, both positively and negatively. The fungal
reductive iron-uptake pathway includes multicopper oxidases, and hence, iron acquisition and
mobilization depends on copper availability [157]. Interestingly, the host also uses copper as a
defense mechanism against Candida by pumping excess quantities of this metal into Candida-
containing phagosomes (Fig 6b) [158]. However, C. albicans adapts to this potential killing
mechanism by differentially modulating the expression of copper- and manganese-dependent
SODs (Sod1 and Sod3, respectively) [159]. Sod1 is expressed when copper is in excess, but
when copper levels decline, Sod3 is then expressed (Fig 6b) [159]. Thus, during infection, C.
albicans is able to adjust copper uptake and management by using it as an enzymatic cofactor
for SOD enzymes [159].
Zinc is an abundant micronutrient that has crucial roles in cellular functionality for both
host and pathogen. The host attempts to limit zinc availability for the fungus by depleting
extracellular zinc levels, mainly via calprotectin, an antimicrobial peptide expressed by neutro-
phils that binds zinc and manganese with high affinity (Fig 6b) [160]. Calprotectin promotes
the antimicrobial activity of neutrophil extracellular traps (NETs), which are released by neu-
trophils after sensing large microbes such as C. albicans hyphae [161–163]. Zinc depletion also
occurs inside immune cells as an antifungal mechanism to kill intracellular pathogens such as
C. albicans and C. glabrata [164]. During infection, macrophages deplete intracellular zinc by
pumping it into the Golgi apparatus via specific ZnT-type zinc transporters (Fig 6b) and
increasing the expression of zinc-binding metallothioneins [165]. Additionally, macrophages
up-regulate the zinc importer ZIP2 to increase the intracellular levels of zinc (Fig 6b) [166].
This combination of strategies depletes zinc from the extracellular environment while dealing
with the increased metabolic demands associated with microbial clearing [166]. To overcome
zinc depletion, C. albicans overexpresses ZRT1 and ZRT2 genes, encoding zinc uptake trans-
porter systems Zrt1 and Zrt2 (Fig 6b). Both transporters are regulated by the zinc finger tran-
scription factor Zap1 (also known as Csr1) [167,168] and by pH [79]. Zinc transporters play
important roles in Candida pathogenesis because overexpression of Zrt2 increases C. albicans
virulence [169]. In addition to functioning as a zinc transporter, Zrt1 also serves as a receptor
for the Pra1 zincophore [79,168], a secreted protein that binds and sequesters zinc from host
PLOS PATHOGENS
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008478 May 21, 2020 13 / 24
cells during C. albicans invasion (Fig 6b) [170]. Similarly to copper, zinc has also been reported
to be pumped in higher amounts into the phagosome to intoxicate internalized pathogens,
constituting an important mechanism of killing (Fig 6b) [171].
Environment-triggered biofilm formation and antifungal resistance
So far, we have described major molecular circuits required by Candida species to counteract
several constraints they face in the human host. The ability of Candida to adapt to these
stresses imparts the flexibility to colonize diverse host niches. The physiological capacity to
respond efficiently to stress and survive hostile environments also endows the fungal cells with
the advantage of being better prepared for future insults [172,173]. The generation of biofilms
might represent another strategy to resist harsh conditions and persist in the human host.
The Candida species most frequently associated with the formation of biofilms, either in
host tissues or implanted medical devices, are C. albicans, C. glabrata, C. tropicalis, and C.
parapsilosis [174]. Biofilms represent three-dimensional communities of adherent cells, with
distinct biological properties, that are embedded in a self-synthesizing extracellular matrix
(ECM) composed predominantly of proteins, glycoproteins, carbohydrates, lipids, and nucleic
acids [175]. The ECM helps to maintain the overall structural integrity of the biofilm, and it
also acts as a physical barrier to drug penetration. Consequently, biofilm cells can survive drug
concentrations more than a thousand times higher than those defined for planktonic cells
[176]. This phenotype is partly associated with the sequestration of drugs by the biofilm ECM
and partly with the occurrence of a subpopulation of so-called “persister cells”. Persister cells
exhibit a dormant-like physiology that has been demonstrated to make them highly resistant
to antifungals [177]. These features contribute to the intrinsic resistance of Candida biofilms
to conventional antifungal treatments, the host immune system, and other environmental per-
turbations, making biofilm-based infections a clinical challenge.
Genome-wide transcriptional profiling and proteomic approaches have identified hundreds
of genes that are differentially expressed between C. albicans biofilm and planktonic cells. The
up-regulation of glycolytic and sulfur amino acid genes, similar to what is observed when cells
grow under hypoxia, suggests that Candida biofilms constitute a heterogeneous environment
with hypoxic niches [178]. Moreover, more than 50 transcriptional regulators and 101 other
genes have functionally validated roles in the formation of Candida biofilms [179–181]. Some
of these play important roles in hyphal formation, adhesion, drug resistance, and matrix pro-
duction (all intrinsic characteristics of biofilms), as well as in stress adaptation. It is not surpris-
ing, then, that adaptation to specific environmental niches modulates the ability of cells to
form biofilms and, consequently, to resist antifungals [54,55,58,59,182–184].
Final remarks and future perspectives
Candida cells regulate specific sets of genes, including many involved in an array of stress and
metabolic pathways, in order to thrive and persist in the human host. In addition to conferring
metabolic flexibility and stress resistance, the physiological reprogramming has been associ-
ated with enhanced virulence through impaired immune recognition, increased biofilm for-
mation, and/or acquired antifungal tolerance and resistance. Although remarkable progress
has been made in the last few decades in our understanding of the impact of host-derived
stresses on Candida physiology and pathogenicity, many details remain unclear. During an
infection, Candida cells are exposed to multiple environmental constraints, sometimes
imposed consecutively, and at other times imposed simultaneously. Yet, in vitro experiments
are predominantly designed to study individual environmental signals, often at single time
points, rather than combinatorial stresses over time. Much progress has been achieved using
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the first approach. While this has given us valuable insights, it rather oversimplifies biological
reality. The analysis of combinatorial stresses and of the dynamism of these inputs would
mimic host conditions more closely and reveal more detailed views of which stress or stresses
prevail and dictate the outcome of different types of infection. The same principle applies to
infection and biofilm models, in which usually interactions between only a few different
microbial populations have generally been examined. Most knowledge in the field comes from
studies of either C. albicans or C. glabrata. Yet, the regulatory circuits required to effectively
respond to each constraint, including antifungal treatments, differ considerably between the
different Candida species, illustrating how heterogeneous these pathogens are. With the
unprecedented emergence of multidrug resistant species such as C. auris, there is an urgent
need to develop new effective antifungals. The integration of omics data with in vivo models,
which mimic host conditions more closely, is now a powerful strategy to unravel molecular
processes underlying adaptive phenotypes. These platforms have already produced novel lines
of research and improved the identification of new potential therapeutic targets for vaccine
and antifungal drug development, enhancing our ability to develop novel strategies to fight
Candida infections.
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